| scholarly article | Q13442814 |
| P2093 | author name string | E S Moland | |
| K S Thomson | |||
| P E Coudron | |||
| P2860 | cites work | beta-Lactamases in laboratory and clinical resistance | Q24669605 |
| Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae | Q24674937 | ||
| A functional classification scheme for beta-lactamases and its correlation with molecular structure | Q24677460 | ||
| Plasmid-encoded AmpC beta-lactamases: how far have we gone 10 years after the discovery? | Q33546289 | ||
| Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. | Q33694016 | ||
| Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants | Q33759195 | ||
| Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut | Q33964309 | ||
| Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes | Q33976721 | ||
| Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli | Q33976746 | ||
| Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens. | Q33976916 | ||
| Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae | Q33977146 | ||
| A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia | Q33977370 | ||
| Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro 48-1220 against beta-lactamases that belong to groups 1, 2b, and 2be. | Q35132969 | ||
| Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. | Q35133558 | ||
| Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia | Q35134043 | ||
| A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. | Q35138291 | ||
| Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests | Q35896953 | ||
| Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find | Q36546913 | ||
| Chromosomally encoded ampC-type beta-lactamase in a clinical isolate of Proteus mirabilis | Q39558426 | ||
| Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins | Q39818693 | ||
| Characterization of beta-lactamases in situ on polyacrylamide gels | Q39851784 | ||
| Plasmid-mediated AmpC-type beta-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum beta-lactams, including moxalactam | Q39865919 | ||
| Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. | Q40014335 | ||
| Plasmid-determined beta-lactamase indistinguishable from the chromosomal beta-lactamase of Escherichia coli | Q40026850 | ||
| Novel plasmid-mediated beta-lactamases in enterobacteriaceae: emerging problems for new beta-lactam antibiotics. | Q41037501 | ||
| Rare case of failure by an automated system to detect extended-spectrum beta-lactamase in a cephalosporin-resistant Klebsiella pneumoniae isolate | Q42725452 | ||
| Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis | Q47998778 | ||
| Transferable class C beta-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC beta-lactamase | Q48007849 | ||
| An extended-spectrum AmpC-type beta-lactamase obtained by in vitro antibiotic selection. | Q48029765 | ||
| Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type beta-lactamase exposed during an outbreak of SHV-5 extended-spectrum beta-lactamase in a Leeds hospital. | Q52867465 | ||
| Plasmid-mediated production of class I (AmpC) beta-lactamase by two Klebsiella pneumoniae isolates from the UK. | Q54186235 | ||
| Production of a plasmid mediated AmpC-like beta-lactamase by a Klebsiella pneumoniae septicaemia isolate. | Q54190508 | ||
| Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins. | Q54345489 | ||
| In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase. | Q54354740 | ||
| Susceptibility to penicillins and cephalosporins in beta-lactamase producing strains of E. coli and relative amount of beta-lactamase produced from these strains. | Q54561475 | ||
| Characterization of the plasmid mediated beta-lactamase BIL-1 | Q67556648 | ||
| Survey of the prevalence of beta-lactamases amongst 1000 gram-negative bacilli isolated consecutively at the Royal London Hospital | Q67998624 | ||
| Identification of a novel plasmid-mediated beta-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae | Q72841737 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| Klebsiella pneumoniae | Q132592 | ||
| veteran | Q193891 | ||
| Proteus mirabilis | Q311273 | ||
| P304 | page(s) | 1791-1796 | |
| P577 | publication date | 2000-05-01 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center | |
| P478 | volume | 38 |
| Q90399071 | A Novel, Integron-Regulated, Class C β-Lactamase |
| Q37366249 | AmpC beta-lactamases |
| Q42009069 | AmpC β-lactamases in nosocomial isolates of Klebsiella pneumoniae from India |
| Q42071028 | Ampc Beta lactamases among gram negative clinical isolates from a tertiary hospital, South India |
| Q95267109 | An African perspective on the prevalence, fate and effects of carbapenem resistance genes in hospital effluents and wastewater treatment plant (WWTP) final effluents: A critical review |
| Q95440380 | Analysis of AmpC beta-lactamase gene in Pseudomonas aeruginosa |
| Q37622029 | Antibiotic-Resistant Extended Spectrum ß-Lactamase- and Plasmid-Mediated AmpC-Producing Enterobacteriaceae Isolated from Retail Food Products and the Pearl River in Guangzhou, China |
| Q35652136 | Biofilm and multidrug resistance in uropathogenic Escherichia coli |
| Q73366783 | Cefpodoxime screening of Escherichia coli and Klebsiella spp. by Vitek for detection of organisms producing extended-spectrum beta-lactamases |
| Q42566982 | Cephalosporin MIC distribution of extended-spectrum-{beta}-lactamase- and pAmpC-producing Escherichia coli and Klebsiella species |
| Q33973139 | Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods |
| Q44640091 | Clinical and Microbiologic Analysis of a Hospital's Extended‐Spectrum β‐Lactamase‐Producing Isolates Over a 2‐Year Period |
| Q33983391 | Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded beta-lactamase from a New York City Klebsiella pneumoniae clinical isolate |
| Q42783545 | Comparision of Three Laboratory Tests for Detection of AmpC β Lactamases in Klebsiella Species and E. Coli |
| Q37597404 | Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan |
| Q36395704 | Current concepts in laboratory testing to guide antimicrobial therapy |
| Q41114363 | Detection of ESBL among AmpC producing enterobacteriaceae using inhibitor-based method |
| Q42278779 | Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution? |
| Q41580373 | Development of a TaqMan multiplex PCR assay for detection of plasmid-mediated ampC β-lactamase genes |
| Q91771330 | ERIC-PCR Genotyping of Acinetobacter baumannii Isolated from Different Clinical Specimens |
| Q34501014 | Epidemic and virulence characteristic of Shigella spp. with extended-spectrum cephalosporin resistance in Xiaoshan District, Hangzhou, China |
| Q34041616 | Evaluation of beta-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC beta-lactamases in well-characterized clinical strains of Klebsiella spp |
| Q54343580 | Evaluation of four phenotypic methods to detect plasmid-mediated AmpC β-lactamases in clinical isolates. |
| Q35155836 | Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE |
| Q38475591 | Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates |
| Q96640269 | Exploring the genetic determinants underlying the differential production of an inducible chromosomal cephalosporinase - BlaB in Yersinia enterocolitica biotypes 1A, 1B, 2 and 4 |
| Q34783021 | Extended-spectrum β-lactamase (ESBL) in Omani Children: Study of prevalence, risk factors and clinical outcomes at Sultan Qaboos University Hospital, Sultanate of Oman |
| Q41067310 | First detection of the Ambler class C 1 AmpC beta-lactamase in Citrobacter freundii by a new, simple double-disk synergy test |
| Q34973735 | First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America |
| Q33642638 | First identification of coexistence of blaNDM-1 and blaCMY-42 among Escherichia coli ST167 clinical isolates |
| Q43261203 | First isolation of blaIMI-2 in an Enterobacter cloacae clinical isolate from China |
| Q43110550 | First report of a nonmetallocarbapenemase class A carbapenemase in an Enterobacter cloacae isolate from Colombia |
| Q37598717 | Four variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland |
| Q37322838 | Frequency of plasmid-mediated AmpC in Enterobacteriaceae isolated in a Brazilian Teaching Hospital. |
| Q54302998 | Frequent detection of plasmid-mediated quinolone resistance (qnr) genes in multidrug-resistant Enterobacteriaceae blood isolates, Hong Kong. |
| Q44132388 | Further modification of the Hodge test to screen AmpC beta-lactamase (CMY-1)-producing strains of Escherichia coli and Klebsiella pneumoniae. |
| Q58766722 | Hypervirulent as a hospital-acquired pathogen in the intensive care unit in Mansoura, Egypt |
| Q54331768 | Identification of genotypes of plasmid-encoded AmpC beta-lactamases from clinical isolates and characterization of mutations in their promoter and attenuator regions. |
| Q43902168 | Identification of plasmid-encoded cephalosporinase ACC-1 among various enterobacteria (Klebsiella pneumoniae, Proteus mirabilis, Salmonella) isolated from a Tunisian hospital (Sfax 997-2000) |
| Q41770003 | Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis |
| Q37023184 | Initial Assessment of the Molecular Epidemiology of blaNDM-1 in Colombia |
| Q44233614 | Investigation of extended-spectrum beta-lactamase in Klebsiellae pneumoniae and Escherichia coli from China |
| Q34120497 | Laboratory surveillance for prospective plasmid-mediated AmpC beta-lactamases in the Kinki region of Japan |
| Q92547760 | Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States |
| Q33982586 | Molecular characterization of a novel plasmid-encoded cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya |
| Q35838632 | Molecular description of plasmid-mediated AmpC β-lactamases among nosocomial isolates of Escherichia coli & Klebsiella pneumoniae from six different hospitals in India |
| Q44668939 | Multidrug-resistant Pseudomonas aeruginosa strains harbouring R-plasmids and AmpC beta-lactamases isolated from hospitalised burn patients in a tertiary care hospital of North India |
| Q37576889 | New method for laboratory detection of AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae |
| Q37713480 | Occurrence of bla DHA-1 mediated cephalosporin resistance in Escherichia coli and their transcriptional response against cephalosporin stress: a report from India |
| Q34753336 | Occurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamases |
| Q38454462 | Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals |
| Q90469195 | Occurrence of β-Lactamase-Producing Gram-Negative Bacterial Isolates in Water Sources in Cali City, Colombia |
| Q41038740 | Outbreak of infection caused by Enterobacter cloacae producing the novel VEB-3 beta-lactamase in China |
| Q24535748 | Plasmid-determined AmpC-type beta-lactamases |
| Q33856282 | Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli |
| Q92503809 | Prevalence and characterization of beta-lactamase-producing Escherichia coli isolates from a tertiary care hospital in India |
| Q33949179 | Prevalence of AmpC and other beta-lactamases in enterobacteria at a large urban university hospital in Brazil |
| Q41995038 | Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China |
| Q37427039 | Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold |
| Q42006424 | Resistance markers and genetic diversity in Acinetobacter baumannii strains recovered from nosocomial bloodstream infections |
| Q42689550 | Role of inducers in detection of blaPDC-mediated oxyimino-cephalosporin resistance in Pseudomonas aeruginosa. |
| Q51062316 | T4-like coliphage ΦKAZ14 virulent to pathogenic and extended spectrum β-lactamase-producing Escherichia coli of poultry origin. |
| Q42554492 | TEM mediated extended spectrum cephalosporin resistance in clinical & environmental isolates of Gram negative bacilli: A report from northeast India. |
| Q37002208 | The Beta Lactam Antibiotics as an Empirical Therapy in a Developing Country: An Update on Their Current Status and Recommendations to Counter the Resistance against Them |
| Q44682729 | The indirect pathogenicity of Stenotrophomonas maltophilia |
| Q54313282 | Total alkaloids from Sophora alopecuroides L. increase susceptibility of extended-spectrum β-lactamases producing Escherichia coli isolates to cefotaxime and ceftazidime. |
| Q43179783 | Unreliable extended-spectrum beta-lactamase detection in the presence of plasmid-mediated AmpC in Escherichia coli clinical isolates. |
| Q40834242 | Use of beta-lactamase inhibitors in disk tests to detect plasmid-mediated AmpC beta-lactamases |
| Q44109391 | Ventilator-associated pneumonia: A review |
Search more.